Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Ryan Zarychanski and Ewan Goligher.
Ryan Zarychanski
Connection Strength
1.102
Ewan Goligher
  1. Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19. N Engl J Med. 2021 Aug 26; 385(9):790-802.
    View in: PubMed
    Score: 0.240
  2. Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19. N Engl J Med. 2021 Aug 26; 385(9):777-789.
    View in: PubMed
    Score: 0.240
  3. Anti-Thrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC): Study design and methodology for an international, adaptive Bayesian randomized controlled trial. Clin Trials. 2020 10; 17(5):491-500.
    View in: PubMed
    Score: 0.225
  4. Anticipating and managing coagulopathy and thrombotic manifestations of severe COVID-19. CMAJ. 2020 10 05; 192(40):E1156-E1161.
    View in: PubMed
    Score: 0.224
  5. Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial. Intensive Care Med. 2021 Aug; 47(8):867-886.
    View in: PubMed
    Score: 0.060
  6. Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial. JAMA. 2020 10 06; 324(13):1317-1329.
    View in: PubMed
    Score: 0.057
  7. Anticoagulant interventions in hospitalized patients with COVID-19: A scoping review of randomized controlled trials and call for international collaboration. J Thromb Haemost. 2020 11; 18(11):2958-2967.
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.